Breo ellipta and Fempatch drug interactions - a phase IV clinical study of FDA data
Summary:
We study 37,379 people who take Breo ellipta (fluticasone furoate; vilanterol trifenatate) and Fempatch (estradiol). There is no drug interaction reported.
The study analyzes what interactions people have when they take Breo ellipta and Fempatch. It is created by eHealthMe based on reports the from the FDA, and is updated regularly.
What is Breo ellipta?
Breo ellipta has active ingredients of fluticasone furoate; vilanterol trifenatate. It is often used in asthma. eHealthMe is studying from 37,362 Breo ellipta users. Check the latest studies of Breo ellipta.
What is Fempatch?
Fempatch has active ingredients of estradiol. eHealthMe is studying from 17 Fempatch users. Check the latest studies of Fempatch.
No report is found.
Do you take Breo ellipta and Fempatch?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Breo ellipta (37,362 reports)
- Fempatch (17 reports)
How the study uses the data?
The study uses data from the FDA. It is based on fluticasone furoate; vilanterol trifenatate and estradiol (the active ingredients of Breo ellipta and Fempatch, respectively), and Breo ellipta and Fempatch (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Carboplatin and Methotrexate Sodium - 3 seconds ago
- Drug interactions of Testosterone and Heparin - 6 seconds ago
- Drug interactions of Maraviroc and Lansoprazole - 9 seconds ago
- Drug interactions of Zyrtec and Asmanex Hfa - 11 seconds ago
- Drug interactions of Diprosone and Zantac - 24 seconds ago
- Could Zocor cause Pancreatic Pseudocyst? - 28 seconds ago
- Could Cymbalta cause Spinal Cord Infection? - 33 seconds ago
- Could Cranberry cause Weight Loss? - 35 seconds ago
- Drug interactions of Letairis and Milk Thistle - 38 seconds ago
- Could Temaz cause Impaired Healing? - 39 seconds ago